Kenyans Kipyokei and Rionoripo received long suspensions for doping, they accused Lempus

Dec 20 (Reuters) – Kenyan Diana Kipyokei has been disqualified as the winner of the 2021 women’s Boston marathon after receiving a six-year ban for using the banned substance triamcinolone acetonide, Athletics Integrity United (AIU) said. said on Tuesday.

Compatriot Purity Rionoripo, winner of the 2017 Paris marathon, has been banned for five years after testing positive for the banned diuretic furosemide and, along with Kipyokei, was found to have hindered the AIU investigation by providing false information or documentation.

Fellow Kenyan Betty Wilson Lempus has been charged with the presence of triamcinolone acetonide. She remains provisionally suspended.

“(We will use) the full extent of our intelligence and investigative capabilities to uncover the truth and keep the sport of track and field clean,” AIU Director Brett Clothier said.

The Boston Athletic Association said that in light of Kipyokei’s penalty, Kenyan Edna Kiplagat is now the 2021 champion. Kiplagat also won the race in 2017.

Three other Kenyan runners were penalized separately on Monday. As of the end of November, 55 Kenyan athletes were sanctioned and eight provisionally suspended, according to the AIU.

Triamcinolone acetonide, a substance prohibited in competition when administered in certain ways, falls under the prohibited category of glucocorticoids, commonly used as therapeutic substances in sports.

Its use is permitted if athletes can provide a waiver or proof that administration is not via a prohibited route.

Furosemide is not known to enhance performance itself, but it can be used to mask the use of other types of doping, according to the World Anti-Doping Agency (WADA).

See also  India foils attempt to beat it up with historic polluters at COP27

Kipyokei’s sample was taken after his victory in Boston last October. Her ban was pushed back to June 27 of this year, when the AIU provisionally suspended her, and her results were disqualified up to and including October 11, 2021.

The AIU said the 28-year-old Kipyokei “provided false/misleading information in trying to explain her AAF (Adverse Analytical Finding), including false documentation that she claimed came from a hospital.”

Furosemide was found in Rionoripo’s urine in an out-of-competition test on May 30 in Kenya, the AIU said.

Rionoripo, 29, said he was prescribed medication to treat an ankle injury and provided supporting documentation, but the AIU said its investigations revealed that he had altered his prescription form to include Lasix, the brand name for furosemide.

Lempus, 31, was tested following her victory at the Harmonie Mutuelle Semi de Paris in September last year.

Kenya placed third in the track and field medal haul at last year’s Tokyo Olympics, but has faced accusations of widespread use of performance-enhancing drugs for years.

The Kenyan government has pledged to commit $5 million a year for the next five years to aid anti-doping efforts, including more testing, research and improvements in anti-doping education.

“(It is) a crucial first step and has the potential to be a game changer because it will ensure that ADAK (the Kenya Anti-Doping Agency) and Athletics Kenya have resources provided to play their role in the fight against doping,” Clothier said. she said.

Athletics Kenya, ADAK and Kenyan Sports Minister Ababu Namwamba did not immediately respond to a request for comment.

See also  Hair loss during pregnancy: When does it stop?, Lifestyle News

Reporting by Hritika Sharma in Bangalore; Edited by Alison Williams and Hugh Lawson

Our standards: The Thomson Reuters Trust Principles.